Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIIB014 in Moderate to Late Stage Parkinson's Disease
NCT00438607Phase 2Completed
- Sponsor
- Biogen
- Start
- Apr 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of vipadenant in Parkinson's disease (PD) (3 arms), sponsored by Biogen. Primary endpoints: Number and proportion of subjects with adverse events, Assessment of clinical laboratory parameters and 2 more. Started Apr 2007; status: completed.
02
Drugs
vipadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00438607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438607.